Literature DB >> 18752596

Pseudomonas aeruginosa diversity in distinct paediatric patient groups.

G A Tramper-Stranders1, C K van der Ent, T F W Wolfs, J L L Kimpen, A Fleer, U Johansen, H K Johansen, N Høiby.   

Abstract

Pseudomonas aeruginosa is a pathogen that often infects patients who are either immunocompromised or have local defects in host defences. It is known that cystic fibrosis (CF) patients are sometimes infected with certain clonal isolates. It is not clear whether these clonal isolates also infect non-CF patients and whether clonality of isolates occurs in other patient groups. The aim of this study was to investigate P. aeruginosa diversity and the occurrence of clones within five distinct paediatric patient groups susceptible to P. aeruginosa infection. P. aeruginosa isolates were cultured from 157 patients (CF first infection (CF-1 group) (29); CF chronic infection (CF-chronic group) (27); urinary tract infection (34); chronic suppurative otitis media (43); and intensive-care hospitalization/immunodeficiency (24)). All 202 phenotypically different isolates were tested for antimicrobial resistance and further typed by pulsed-field gel electrophoresis. Simpson's diversity index was calculated for the five groups. CF-chronic patients carried the highest number of distinct P. aeruginosa phenotypes and genotypes per culture. Isolates from the CF-chronic group were significantly less diverse than those from the other groups. A group of clonal isolates was observed among patients from the CF-chronic and CF-1 groups. These or different clonal isolates were not encountered among the three other patient groups. No characteristic resistance pattern could be identified among isolates from the distinct patient groups and among the clonal isolates. In conclusion, isolates of the CF-chronic group were less diverse than those in the other patient groups with P. aeruginosa infection; clonal isolates were not encountered in non-CF patients. Transmission of clonal CF isolates to other patient groups was not observed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752596     DOI: 10.1111/j.1469-0691.2008.02054.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

Review 1.  Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.

Authors:  Axel Dalhoff
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Pseudomonas aeruginosa genotype prevalence in Dutch cystic fibrosis patients and age dependency of colonization by various P. aeruginosa sequence types.

Authors:  Rosa van Mansfeld; Rob Willems; Roland Brimicombe; Harry Heijerman; Ferdinand Teding van Berkhout; Tom Wolfs; Cornelis van der Ent; Marc Bonten
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

3.  Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999-2012.

Authors:  Latania K Logan; Sumanth Gandra; Siddhartha Mandal; Eili Y Klein; Jordan Levinson; Robert A Weinstein; Ramanan Laxminarayan
Journal:  J Pediatric Infect Dis Soc       Date:  2017-11-24       Impact factor: 3.164

4.  Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting.

Authors:  Timothy J Kidd; Stephen R Ritchie; Kay A Ramsay; Keith Grimwood; Scott C Bell; Paul B Rainey
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

5.  Pseudomonas aeruginosa infection among cystic fibrosis and ICU patients in the referral children medical hospital in Tehran, Iran.

Authors:  Z Movahedi; B Pourakbari; S Mahmoudi; F Sabouni; M T Ashtiani Haghi; R Hosseinpour Sadeghi; S Mamishi
Journal:  J Prev Med Hyg       Date:  2013-03

Review 6.  Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases.

Authors:  Marta Garcia-Clemente; David de la Rosa; Luis Máiz; Rosa Girón; Marina Blanco; Casilda Olveira; Rafael Canton; Miguel Angel Martinez-García
Journal:  J Clin Med       Date:  2020-11-24       Impact factor: 4.241

7.  Emergence of Pseudomonas aeruginosa cross-infection in children with cystic fibrosis attending an Iranian referral pediatric center.

Authors:  M Ghazi; G Khanbabaee; F Fallah; B Kazemi; S Mahmoudi; M Navidnia; B Pourakbari; B Bakhshi; H Goudarzi
Journal:  Iran J Microbiol       Date:  2012-09

8.  Within-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis.

Authors:  Rosa van Mansfeld; Mark de Been; Fernanda Paganelli; Lei Yang; Marc Bonten; Rob Willems
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.